Home › Compare › MACE vs JNJ

MACE vs JNJ: Dividend Comparison 2026

MACE yields 12755.10% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MACE wins by $608983385379492992.00M in total portfolio value
10 years
MACE
MACE
● Live price
12755.10%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608983385379492992.00M
Annual income
$599,734,007,652,903,040,000,000.00
Full MACE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MACE vs JNJ

📍 MACE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMACEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MACE + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MACE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MACE
Annual income on $10K today (after 15% tax)
$1,084,183.67/yr
After 10yr DRIP, annual income (after tax)
$509,773,906,504,967,570,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MACE beats the other by $509,773,906,504,967,570,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MACE + JNJ for your $10,000?

MACE: 50%JNJ: 50%
100% JNJ50/50100% MACE
Portfolio after 10yr
$304491692689746496.00M
Annual income
$299,867,003,826,451,520,000,000.00/yr
Blended yield
98.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MACE
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-23.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MACE buys
0
JNJ buys
0
No recent congressional trades found for MACE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMACEJNJ
Forward yield12755.10% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$608983385379492992.00M ✓$20.0K
Annual income after 10y$599,734,007,652,903,040,000,000.00 ✓$827.78
Total dividends collected$608370149691184512.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: MACE vs JNJ ($10,000, DRIP)

YearMACE PortfolioMACE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,286,210$1,275,510.20$10,676$355.77+$1.28M → MACE
2$154,700,940$153,324,695.32$11,407$389.39+$154.69M → MACE
3$17,400,452,519$17,234,922,513.08$12,198$426.53+$17400.44M → MACE
4$1,830,347,112,806$1,811,728,628,610.28$13,056$467.62+$1830347.10M → MACE
5$180,066,003,138,319$178,107,531,727,616.94$13,987$513.12+$180066003.12M → MACE
6$16,568,253,739,746,314$16,375,583,116,388,312.00$14,998$563.56+$16568253739.73M → MACE
7$1,425,907,501,105,968,400$1,408,179,469,604,439,800.00$16,098$619.52+$1425907501105.95M → MACE
8$114,788,926,162,030,820,000$113,263,205,135,847,460,000.00$17,295$681.69+$114788926162030.81M → MACE
9$8,644,278,249,149,733,000,000$8,521,454,098,156,358,000,000.00$18,599$750.82+$8644278249149733.00M → MACE
10$608,983,385,379,493,000,000,000$599,734,007,652,903,040,000,000.00$20,022$827.78+$608983385379492992.00M → MACE

MACE vs JNJ: Complete Analysis 2026

MACE — Stock

Mace Security International, Inc. designs, manufactures, and sells personal safety and security products to retailers, distributors, and individual consumers worldwide. The company offers pepper sprays, gels, and guns, as well as animal deterrent sprays; personal alarms; stun guns; and combo kits under the Mace brand, as well as self defense products for women. It also sells tactical spray products and systems to law enforcement, security professionals, correctional institutions, and military markets. The company distributes and supports its branded products and services through mass market retailers, wholesale distributors, independent dealers, e-commerce marketers, and installation service providers, as well as Mace.com website. Mace Security International, Inc. was founded in 1965 and is headquartered in Cleveland, Ohio.

Full MACE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MACE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MACE vs SCHDMACE vs JEPIMACE vs OMACE vs KOMACE vs MAINMACE vs ABBVMACE vs MRKMACE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.